Treatment Combination Improves Survival in Platinum-resistant Ovarian Cancer
Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
Progress Against Cancer
Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.
Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise of early-onset cancers.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
Steroids at the start of immunotherapy can negatively affect response, and colorectal cancer may lead to sexual side effects in women.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More